RxDoctor Payments DataLook up a doctor →

Timothy Jennings, DO

Family Medicine · Maryland Heights, MONPI 1548233455

Payments from drug & device makers

$30,159,032in general payments, 2019–2025

Across 1,061 payments — averaging $28,425 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$25.5M
  • Modernatx, Inc.$2.1M
  • Eli Lilly$1.1M
  • Eisai Inc.$956K
  • AstraZeneca$485K
  • Amarin Pharma, Inc.$3K
  • plus $5K from 8 others
$82,109in research payments, 2019–2025

Across 14 payments — averaging $5864.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$70K
  • Pfizer$12K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$30,159,032 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$40,528
Medicare patients
211
Services billed
413

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Maryland Heights

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →